Sign In
Buy NVO
$47.42
+1.52 (+3.31%)
At Close: Jun 23, 2026
Banco Santander S.A. Sells 63,587 Shares of Novo Nordisk A/S $NVO
04:28am, Saturday, 28'th Feb 2026
Banco Santander S.A. cut its position in shares of Novo Nordisk A/S (NYSE: NVO) by 42.9% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The fun
Novo Nordisk Shares Sink 21% as Obesity Shot Trails Lilly Rival
01:35pm, Friday, 27'th Feb 2026
Novo Nordisk (NVO) has now surrendered the last of the gains that followed the 2021 US approval of Wegovy, marking a decisive turn in what had been one of Europ
Why I'm Still Bullish On Novo Nordisk Despite Recent Setbacks
06:33am, Friday, 27'th Feb 2026
Novo Nordisk is repriced as if its fundamentals have sharply deteriorated, despite strong underlying demand and market expansion drivers. NVO projects a 5-13% decline in 2026 sales and profits, mainly
Forget Altimmune: This Proven Obesity‑Drug Giant Is the Better Weight‑Loss Play
04:40pm, Thursday, 26'th Feb 2026
Altimmune and Novo Nordisk have encountered some headwinds in recent years. Both could rebound, but one of them looks far more likely to do so.
Why Shares of Novo Nordisk Stock Sank (Again) This Week
03:39pm, Thursday, 26'th Feb 2026
The weight-loss drug innovator is falling behind in the industry and facing major pricing pressures.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novo Nordisk A/S - NVO
03:18pm, Thursday, 26'th Feb 2026
NEW YORK, Feb. 26, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE: NVO). Such investors are advised to
Viking Therapeutics: The High-Stakes Weight Loss Contender
02:37pm, Thursday, 26'th Feb 2026
The pharmaceutical industry is currently witnessing a historic gold rush surrounding obesity treatments. While industry titans like Novo Nordisk NYSE: NVO and Eli Lilly NYSE: LLY dominate the headline
Commitments Received for ~A$8.2m Placement
09:23am, Thursday, 26'th Feb 2026
Not for release to US wire service or distribution in the United States PERTH, Western Australia, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Novo Resources Corp. (“Novo” or the “Company”) (ASX: NVO) (T
Anthropic Excites But Doesn't Replace
06:42am, Thursday, 26'th Feb 2026
Anthropic's latest product showcase got people talking about AI replacing enterprise software, but Wedbush thinks those fears are getting ahead of reality.At it
Novo Nordisk: Can't Ignore It At These Valuations (Rating Upgrade)
06:17am, Thursday, 26'th Feb 2026
Novo Nordisk: Can't Ignore It At These Valuations (Rating Upgrade)
Cypress Asset Management Inc. TX Trims Stake in Novo Nordisk A/S $NVO
04:49am, Thursday, 26'th Feb 2026
Cypress Asset Management Inc. TX lessened its holdings in Novo Nordisk A/S (NYSE: NVO) by 79.0% during the third quarter, according to its most recent disclosure with the SEC. The institutional invest
Stock Market Today, Feb. 25: Novo Nordisk Dips After Announcing $2.1 Billion Partnership With Vivtex for Oral Drug-Delivery Technologies
05:52pm, Wednesday, 25'th Feb 2026
Expand NYSE: NVO Novo Nordisk Today's Change (-1.11%) $-0.43 Current Price $38.16 Key Data Points Market Cap $130B Day's Range $37.65 - $38.24 52wk Range $37.65 - $91.90 Volume 55M Avg Vol 22M Gross M
Market Today: Nvidia beats, Meta chip deals, Amex HQ move
05:37pm, Wednesday, 25'th Feb 2026
Guru Stock PicksDavid Herro has made the following transactions:Reduce in CNH by 1.5%Sold out in XAMS:EXOAdd in TSE:6273 by 1.02%New position in LSE:ULVROakmark
Novo Partners Vivtex in Deal Worth Up to $2.1 Billion
01:01pm, Wednesday, 25'th Feb 2026
Novo Nordisk (NVO) has moved to reinforce its long-term growth narrative, announcing a partnership with US biotech Vivtex Corp. that could be worth up to $2.1 b
1 Reason Why I'd Hold This Weight‑Loss Drug Leader Through Any Market Crash
01:00pm, Wednesday, 25'th Feb 2026
Although pegged as a weight-loss stock, this drug maker's core business has long been diabetes.
